Svas Biosana, an Italy-based medical devices company, has raised €6m ($8m) from IMI Fondi Chiusi and from Banca Intesa’s Atlante Private Equity.

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.